JP Morgan Chase’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $19.6M | Buy |
1,059,864
+49,604
| +5% | +$1.47M | ﹤0.01% | 2091 |
|
|
2025
Q4 | $31.4M | Buy |
1,010,260
+701,127
| +227% | +$19.2M | ﹤0.01% | 1687 |
|
|
2025
Q3 | $6.67M | Sell |
309,133
-106,856
| -26% | -$1.93M | ﹤0.01% | 3111 |
|
|
2025
Q2 | $5.82M | Buy |
415,989
+117,439
| +39% | +$1.59M | ﹤0.01% | 3011 |
|
|
2025
Q1 | $4.02M | Sell |
298,550
-5,784
| -2% | -$98.5K | ﹤0.01% | 3347 |
|
|
2024
Q4 | $5.83M | Sell |
304,334
-96,017
| -24% | -$2.09M | ﹤0.01% | 3205 |
|
|
2024
Q3 | $9.11M | Buy |
400,351
+274,641
| +218% | +$4.49M | ﹤0.01% | 2686 |
|
|
2024
Q2 | $1.64M | Buy |
125,710
+76,687
| +156% | +$1.06M | ﹤0.01% | 3947 |
|
|
2024
Q1 | $858K | Sell |
49,023
-7,915
| -14% | -$153K | ﹤0.01% | 4459 |
|
|
2023
Q4 | $1.24M | Buy |
56,938
+6,016
| +12% | +$95K | ﹤0.01% | 4191 |
|
|
2023
Q3 | $781K | Sell |
50,922
-9,050
| -15% | -$173K | ﹤0.01% | 4231 |
|
|
2023
Q2 | $1.43M | Buy |
59,972
+10,595
| +21% | +$272K | ﹤0.01% | 3794 |
|
|
2023
Q1 | $1.26M | Sell |
49,377
-122,982
| -71% | -$3.94M | ﹤0.01% | 3877 |
|
|
2022
Q4 | $5.03M | Buy |
172,359
+103,101
| +149% | +$2.38M | ﹤0.01% | 2807 |
|
|
2022
Q3 | $1.42M | Buy |
69,258
+50,919
| +278% | +$915K | ﹤0.01% | 3748 |
|
|
2022
Q2 | $213K | Sell |
18,339
-327
| -2% | -$4.39K | ﹤0.01% | 5050 |
|
|
2022
Q1 | $345K | Buy |
18,666
+5,633
| +43% | +$108K | ﹤0.01% | 4913 |
|
|
2021
Q4 | $258K | Buy |
+13,033
| New | +$243K | ﹤0.01% | 5213 |
|
|
2021
Q2 | – | Sell |
-10
| Closed | – | – | 6650 |
|
|
2021
Q1 | $0 | Buy |
+10
| New | +$187 | ﹤0.01% | 6391 |
|
|
2020
Q4 | – | Sell |
-21,290
| Closed | -$255K | – | 5967 |
|
|
2020
Q3 | $255K | Hold |
21,290
| – | – | ﹤0.01% | 4261 |
|
|
2020
Q2 | $354K | Hold |
21,290
| – | – | ﹤0.01% | 4003 |
|
|
2020
Q1 | $142K | Hold |
21,290
| – | – | ﹤0.01% | 4406 |
|
|
2019
Q4 | $153K | Hold |
21,290
| – | – | ﹤0.01% | 4772 |
|
|
2019
Q3 | $233K | Sell |
21,290
-2,660
| -11% | -$58.8K | ﹤0.01% | 4565 |
|
|
2019
Q2 | $794K | Buy |
23,950
+2,238
| +10% | +$89.8K | ﹤0.01% | 3993 |
|
|
2019
Q1 | $909K | Sell |
21,712
-4,429
| -17% | -$200K | ﹤0.01% | 3864 |
|
|
2018
Q4 | $1.19M | Buy |
26,141
+1,944
| +8% | +$112K | ﹤0.01% | 3633 |
|
|
2018
Q3 | $2.03M | Buy |
24,197
+476
| +2% | +$44.9K | ﹤0.01% | 3455 |
|
|
2018
Q2 | $2.28M | Buy |
23,721
+1,881
| +9% | +$199K | ﹤0.01% | 3316 |
|
|
2018
Q1 | $2.3M | Sell |
21,840
-63
| -0.3% | -$6.84K | ﹤0.01% | 3170 |
|
|
2017
Q4 | $3.43M | Buy |
21,903
+613
| +3% | +$78.1K | ﹤0.01% | 2974 |
|
|
2017
Q3 | $2.82M | Buy |
+21,290
| New | +$3.58M | ﹤0.01% | 2952 |
|
Other funds holding VRDN
BG
VCM
FFM
VA
PBA